ArticleWorld journal of surgical oncology2025
Exploring the prognosis of rictor(+) in high-risk population: lasso regression for enhancing overall survival in primary gastric adenocarcinoma.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo identify optimal methods for predicting survival in high-risk Rictor (+) gastric adenocarcinoma patients post-gastrectomy.
methods676 patients diagnosed with gastric adenocarcinoma and Rictor (+) status who underwent radical gastrectomy at three medical centers between May 2005 and December 2022 were analyzed. The prognostic variables linked with overall survival were meticulously evaluated through the sophisticated lenses of multiple Cox Proportional Hazards regression and Lasso regression analyses.
resultsThe Cox regression model included gender, age, positive lymph node count, and biomarkers (HER2, P27, P53), achieving a C-index of 0.759 (95% CI: 0.723–0.796). The Lasso regression model incorporated age, pT stage, lymph node involvement, neural invasion, and tumor diameter, demonstrating superior predictive accuracy (C-index: 0.797; 95% CI: 0.729–0.865). Both models outperformed the AJCC 8th edition TNM staging system (C-index: 0.69, 95% CI: 0.659–0.722). Calibration curves revealed strong concordance between predicted and observed survival outcomes. Decision curve analysis affirmed clinical utility, while risk reclassification metrics showed significant improvements over AJCC staging: net reclassification improvement (NRI) reached 0.218 (P < 0.01) and 0.178 (P = 0.033) in training and validation cohorts, respectively, with integrated discrimination improvement (IDI) values of 0.085 (P < 0.01) and 0.059 (P = 0.028).
conclusionOur findings underscore the enhanced predictive accuracy of Lasso regression over the traditional Cox regression model for identifying high-risk gastric adenocarcinoma patients with Rictor (+) status post-gastrectomy. This novel analytical approach may represent a pivotal advance in the stratification of patients at elevated risk, potentially guiding more precise preventive and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.